Samantha Allen PharmD Candidate 2012 Case Presentation April 19, 2012 Alcohol Withdrawal Management.

Slides:



Advertisements
Similar presentations
Alcohol: Research to Practice Gail D’Onofrio MD, MS Section of Emergency Medicine Yale University School of Medicine.
Advertisements

Best Practice Tom Shiffler, MD 7/23/10
Central Nervous System Depressants
Saving Lives By Strengthening Our Region’s Trauma Care System December 5, 2013 MANAGEMENT OF THE INJURED PATIENT IN ALCOHOL WITHDRAWAL.
Medication Assisted Treatment: An Introduction Deborah A. Orr, Ph.D., RN Remington College School of Nursing.
Toxin-Induced Seizures: Life-Threatening Forms of Withdrawl ACEP Scientific Assembly 2003, Boston, MA.
Drug Intoxication and Withdrawal: Signs and Symptoms.
Joanna Piechniczek-Buczek, MD Boston University
By : dr.noor Alcohol& related mental disorders By: Dr.Noor.
Chapter 8: Chronic Alcohol Third leading preventable cause of death in the US.
Serotonin syndrome: A literature review of therapeutic options? Rob Hall MD, PGY4 FRCPC Emergency Medicine Nov 8, 2003.
Delirium Tremens Jaymie McAllister EBP Presentation November 5, 2012.
Alcohol Pharmacology Acute and Chronic use and the effects on Anaesthesia Alcohol withdrawal.
7: Managing withdrawal Objectives
Keri Holmes-Maybank, MD Cathryn Caton, MD, MS MUSC June 21, 2012
Addiction & Alcoholism. I. Addiction and its Two Key Forms A. Addiction: a condition in which an individual requires the use of a drug or the participation.
Hepatic Encephalopathy in End-Stage Liver Disease Megan Dudley End of Life Care for Adults and Families The University of Iowa College of Nursing 1.
TRAUMA CARE BEYOND THE ED
Drug-Induced Seizures (in 15 minutes or Less) Robert S. Hoffman, MD Director, NYC Poison Center Associate Professor Emergency Medicine and Medicine NYU.
Inpatient Management of Alcohol Withdrawal
A LCOHOL USE DISORDER. A LCOHOL USE IN I NDIA 21% of adult males use alcohol (Ray et al, 2004) 5% women use alcohol (Benegal et al, 2005) 50% of all drinkers.
CIWA Protocol: Fraser Health
Chapter 9 Alcohol Acute effects Mechanisms of action Long-term effects
Alcohol Withdrawal Resident Rounds July 10, 2007 Maggie Gordon, R2.
PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES
Chapter 10 - Sedatives.  Sedative-Hypnotics: calm us down and produce sleep  Antianxiety Drugs: tranquelizers.
Alcohol Dr Alison Battersby.
Conscious Sedation.
Sedatives & Hypnotics. Sedatives The perfect sedative reduces anxiety with little or no effect on motor or mental function within the therapeutic dosing.
Mechanism of action It interacts with specific receptors in the CNS, particularly in the cerebral cortex. Benzodiazepine-receptor binding enhances the.
B ENZODIAZEPINE DEPENDENCE. WHO - ICD 10 C RITERIA FOR S UBSTANCE D EPENDENCE A definite diagnosis of dependence syndrome should usually be made only.
2009 Pandemic Education Package Pharmacology Review.
Drugs Used in Mental Health Antianxiety Drugs. Anxiety – a feeling of apprehension, worry, or uneasiness that may or may not e based on reality Anxiolytics.
Alcohol Withdrawal Syndrome
 Sally, a 33 year old legal secretary, is admitted to your ward after being involved in a MVA  She has a past history of poly drug use and last used.
Alcohol Withdrawal Syndromes
Clinical Management Course: Medical Complications of Alcoholism Peter R. Martin, M.D. Professor of Psychiatry and Pharmacology.
Mental Health Nursing: Pharmacology: Anti-anxiety Medications C. Calzolari 2016.
Liaison and Emergency Psychiatry Moray 1 Alcohol dependence and Safe Withdrawal In-patient detox in Dr Grays.
 Librium is mainly indicated to manage moderate to severe anxiety. It contains generic Chlordiazepoxide as a main therapeutic agent and it belongs to.
March 2016 ALCOHOL WITHDRAWAL.  Recognition of alcohol withdrawal symptoms  Ensuring appropriate treatment so that complications are prevented  Describing.
Patty Ghazvini, PharmD., CGP. Associate Professor of Pharmacy Practice FAMU College of Pharmacy.
SUBSTANCE ABUSE Substance: any drug, medication, or toxin that shares potential for abuse Addiction: physiologic/psychologic dependence causing withdrawal.
Parenteral Vitamin Repletion in Alcohol Use Disorder Vicki P. Cheng, Cory Taylor UCI Internal Medicine Residency Cost-Conscious Medicine Series.
ALCOHOL WITHDRAWAL: PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT
INTRODUCTION Acute alcohol withdrawal syndrome occurs when individuals with alcohol dependency abruptly stop or substantially reduce their alcohol consumption.
Managing Alcohol and Opioid Withdrawals
1 Play file: 0 - Tequila. 2 The Medical Management of A LCOHOL W ITHDRAWAL John J. Stasinos, M.D. LTC(P), MC, USA Chief, Chemical Addictions Treatment.
 Discuss the symptoms and signs of alcohol withdrawal.  Discuss the management of alcohol withdrawal.
Librium 25 mg Medication for Alcohol Withdrawal from GenericEPharmacy Librium 25 mg medicationLibrium 25 mg medication is very effective in providing relief.
Hypertensive Disorders of Pregnancy - Dr Thomas Carins
Drugs used for anxiety and panic disorders
Drugs used for anxiety and panic disorders
Delirium in the Last Hours and Days of Life (updated) Dr Dan Monnery
Managing Alcohol and Opioid Withdrawals
Alcohol Detoxification
Anxiolytics, Sedatives and Hypnotic
Following this training the nurse will be able to:
Update Training on CIWA and COWS
Reset your Stressed Life in Healthy Life with Librium Medication
Complex Management of Gamma Hydroxyl Butyrate Withdrawal
Alcohol Withdrawal in Acute Care
Medications for Dementia
UCI internal medicine mini-lecture series By Julia Kao
Chapter 38 Drug Abuse II: Alcohol 1.
Metronidazole By Rajesh Patel.
Delirium
Alcohol Use Disorder Assessment & Treatment Strategies
Anxiolytic and hypnotic drugs
For PAWWS (> or = 4) or CIWA (> or = 9)
Presentation transcript:

Samantha Allen PharmD Candidate 2012 Case Presentation April 19, 2012 Alcohol Withdrawal Management

Objectives: Define the pathophysiology of alcohol withdrawal Identify common symptoms List first line pharmacologic treatment options Identify appropriate adjunctive treatment agents

Pathophysiology Withdrawal results from an imbalance in the brain of inhibitory and excitatory neurotransmitters Glutamate Alcohol inhibits NMDA receptor Prevents binding of glutamate, an excitatory neurotransmitter Chronic alcohol exposure leads to up-regulation of NMDA receptor GABA Alcohol increases effect of GABA, an inhibitory neurotransmitter Results in a decrease in overall brain excitability Chronic alcohol exposure leads to a decrease in GABA-A neuroreceptor Hyperexcitability results from abrupt cessation of alcohol Manifests symptomatically

Presenting Symptoms 6 to 12 hours after cessation of alcohol: Minor symptoms- Insomnia, tremulousness, mild anxiety, GI upset, headache, diaphoresis, palpitations, anorexia 12 to 24 hours: Alcoholic hallucinosis- Visual, auditory, or tacticle hallucinations 24 to 48 hours: Withdrawal seizures- Generalized tonic-clonic seizures 48 to 72 hours: Alcohol withdrawal delirium- Hallucinations, disorientation, tachycardia, hypertension, low-grade fever, agitation, diaphoresis

Diagnostic Criteria Cessation of or reduction in alcohol use that has been heavy and prolonged 2 + of the following within several hours of cessation: -Autonomic hyperactivity-Increased hand tremor -Insomnia-Nausea or vomiting -Psychomotor agitation-Anxiety -Grand mal seizures -Transient visual, tactile, or auditory hallucination or illusions Above symptoms cause a significant distress or impairment in social and occupational function Symptoms are not due to a general medical condition and are not better accounted for by a mental disorder

Routine Labs CBC with DiffMagnesium PTCMP LFTINR CalciumGGTP PTTVit. B-12 UaBlood Alcohol Level FolateTSH Urine Drug Screen

Alcohol Withdrawal Scale (AWS)

CIWA-Ar Scale

CIWA-Ar Scale – “AWS Scale” Categories: Nausea/VomitingTactile Disturbances TremorAuditory Disturbances Paroxysmal sweatsVisual Disturbances AnxietyHeadache (fullness is head) Agitation Orientation & Clouding of sensorium Scale 0-7 for most categories Maximum Score 67 Initiate treatment when AWS score >6

Goals of Treatment Provide a safe withdrawal from the drug and enable the patient to be drug free Provide a withdrawal that is humane and protects the patient’s dignity Prepare the patient for ongoing treatment of his or her dependence on alcohol

Guidelines for ETOH Withdrawal Prophylaxis Regimens

Optional Diazepam (Valium ® ) Loading Dose NOT recommended elderly, severe liver disease, or compromised hepatic function AWS 6-9 (moderate withdrawal) Diazepam 20 mg PO q1hr x 3 OR Diazepam 10 mg IV q1hr x 6 doses if unable to take PO AWS 10+ (complicated withdrawal) Diazepam 20 mg IV x 1 Repeat q1hr until the patient is sedated but arousable

Nursing Monitoring Parameters- Diazepam Load Routine Telemetry monitoring during load Monitor O 2 saturation during load STOP if: Patient becomes hypersomnolent Difficult to arouse Signs respiratory depression RR <10 Pulse ox <92%

Chlordiazepoxide (Librium ®) Regimen Who: Patients with Normal AST/ALT (no significant liver dysfunction present) Criteria: AWS Score ≥6 Regimen: 50 mg PO q4hr x 24 hr; then 50 mg PO q6hr x 24 hr; then 25 mg PO q4hr x 24 hr; then 25 mg PO q6hr x24 hr; then 25 mg PO q8hr x 24hr; then discontinue Additional Dosing: 50 mg PO q4hr PRN

Nursing Monitoring Parameters- Chlordiazepoxide Assess AWS scale 1 hour after each dose May give PRN dose if AWS >7 Maximum dosage 600 mg/24hr Hold ANY dose if: Patient is sleeping or somnolent Patient has signs of ataxia Patient has signs respiratory depression RR<10 Pulse ox <92%

Lorazepam (Ativan ® )Regimen Who: Patients with significant liver dysfunction, the elderly, or if NPO Criteria: AWS Score ≥6 Regimen: 2 mg PO q4hr x 48 hr; then 1 mg PO q6hr x 24 hr; then 1 mg PO q8hr x 24 hr; then 1 mg PO q6hr x24 hr; then discontinue **May give IV if unable to take PO** Additional Dosing: 2 mg PO or IV q4hr PRN

Nursing Monitoring Parameters- Lorazepam Assess AWS scale 1 hour after each dose May give PRN dose if AWS >7 Maximum dosage 20 mg/24hr Hold ANY dose if: Patient is sleeping or somnolent Patient has signs of ataxia Patient has signs respiratory depression RR<10 Pulse ox <92%

Additional Routine Medications

Common Scheduled Medications Thiamine 100 mg/50 mL D5W over 30 minutes STAT, then Q8hr x additional 2 doses, then 100 mg PO or IV daily Folic Acid 1 mg PO daily Multivitamin 1 capsule PO daily B-Complex Vitamin 1 tablet PO daily IV fluids mL/hr

Common PRN Medications Vitamin K 5 mg SQ* x 1 if INR >1.3 If not on warfarin Bismuth (Pepto-Bismol) 30 mL PO PRN diarrhea after each loose stool (max 6 doses/24hr) Lorazepam(Ativan ® )1 mg PO or IV q4hr PRN anxiety Ondansetron (Zofran ® ) 4 mg IV q8hr PRN N/V Haloperidol (Haldol ® ) 3 mg IM or IV q4hr PRN agitation (hold if Qtc >500) *SQ administration not routinely recommended, IV preferred

QUESTIONS???

References: Grandview Hospital Physician’s Orders: Alcohol (ETOH) Withdrawal Management. 01/2010. Bayard M, Mcintyre J, Hill KR et al. Alcohol Withdrawal Syndrome. Am Fam Physician. 2004;69(6):